| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Data elements collected/recorded by AdVeritas from package inserts | Definition | Equivalent to LIVD column | Equivalent to expanded APHL LIVD file | Comment | Column headers from | ||||||||||||||||||||
2 | Done? (Y) | Entry ready for release - choices are: Not yet / Check / Ready / Ready - no notes / Ready (correction) / Ready* / Airtable / Y / N | Publication Version ID | this mapping for when test included in LIVD file - until then, this would be empty, corresponding to No | ||||||||||||||||||||||
3 | Company/Organization | Manufacturer name of the IVD test | Manufacturer | |||||||||||||||||||||||
4 | Test Name | Model | or Manufacturer Analyte Name? | |||||||||||||||||||||||
5 | *URL | publicly available URL to the test in the FDA table | Adveritas file | should probably also record when accessed, as we noticed, that sometimes URLs are reused! | ||||||||||||||||||||||
6 | Test Type (Lab or Kit) | indicates what the package insert refers to - choices are: Kit / Lab / Collection | Adveritas file | |||||||||||||||||||||||
7 | Country of Origin | manufacturer location | Adveritas file | |||||||||||||||||||||||
8 | US Regulatory Status | choices are: EUA granted / 510k / ??? | Adveritas file | |||||||||||||||||||||||
9 | Category | Type of test - choices are: Lab / POCT / Home / Lab + POCT / Home + POCT | Adveritas file | |||||||||||||||||||||||
10 | Authorized Setting(s) per FDA | CLIA Complextity; multi-select allowed - choices are: H = high / M = medium/ W = waived / Home | Adveritas file | |||||||||||||||||||||||
11 | Authorized Settings | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
12 | Technology | Category of technology used - choices are: antigen / molecular / serology | Adveritas file | check mapping | ||||||||||||||||||||||
13 | Test Type | Expanded LIVD file in use by CDC | check mapping | |||||||||||||||||||||||
14 | Analyte | Analyte detail - choices are: RNA / antigen / IgM / IgG / IgG/IgM / IgA/IgG/IgM | Adveritas file | |||||||||||||||||||||||
15 | Assay | type of test - choices are: rRT-PCR / Isothermal Amplification /Lateral Flow /Heterogeneous Immunoassay /Homogeneous Immunoassay /Heterogeneous Immunoassay (CLIA) /NGS /ELISA /qSTAR / RT-PCR, MALDI-TOF / TMA, DKA / DETECTR/ RT-LAMP | Adveritas file | check mapping | ||||||||||||||||||||||
16 | Vendor Method | Column header from LIDR group K+ file | ||||||||||||||||||||||||
17 | Test Method | Expanded LIVD file in use by CDC | check mapping | |||||||||||||||||||||||
18 | Specimen Type | Allowed specimen types - choices are: NP swab / OP swab / ANs swab / MTNs swab / Ns swab / Sal / Spu / Ns aspirate / Ns wash / NP aspirate / NP wash / BAL / Ser / Pla / VWB | Vendor Specimen Description | Adveritas file | ||||||||||||||||||||||
19 | Transport Media | allowed transport media - choices are: NA / ND / VTM / UTM / Saline / VTM, Amies transport medium, saline | Adveritas file | |||||||||||||||||||||||
20 | Gene | target genes for molecular tests - choices are: NA / N / E / S / ORF1ab / N (N1, N2) | Adveritas file | assume multi-select is allowed | ||||||||||||||||||||||
21 | Antigen | AG targeted - choices are: NA / ND / N / S | Adveritas file | |||||||||||||||||||||||
22 | Sample Prep | describes sample preparation - choices are: NA = not applicable / Manual / descripton of process used and identification of instrument used, if applicable | Adveritas file | |||||||||||||||||||||||
23 | Detection | identifies the instrument used for detection | Equipment UID | Adveritas file | ||||||||||||||||||||||
24 | Equipment UID Type | Adveritas file | ||||||||||||||||||||||||
25 | TAT | turn around time (free text) | Adveritas file | |||||||||||||||||||||||
26 | Analytical Sensitivity (LOD) | Level of detection | Adveritas file | |||||||||||||||||||||||
27 | LOD of FDA Reference Panel (NDU/mL) | Adveritas file | ||||||||||||||||||||||||
28 | Cross- Reactivity | overall impression of reported cross-reactivity with other viruses | Adveritas file | |||||||||||||||||||||||
29 | PPA/Sensitivity | Adveritas file | ||||||||||||||||||||||||
30 | PPA Sample Size | Adveritas file | ||||||||||||||||||||||||
31 | PPA Specimen Type | identifies if just clinical samples or also pooled clinical samples were used | Adveritas file | |||||||||||||||||||||||
32 | NPA/Specificity | Adveritas file | ||||||||||||||||||||||||
33 | NPA Sample Size | Adveritas file | ||||||||||||||||||||||||
34 | NPV @ 5% prevalence | Adveritas file | ||||||||||||||||||||||||
35 | PPV@ 5% prevalence | Adveritas file | ||||||||||||||||||||||||
36 | Manufacturer's Validation Notes | free text | Adveritas file | |||||||||||||||||||||||
37 | External Quality Control | Choices are: Included / Excluded / NA = not applicable some free text added sometimes | Adveritas file | |||||||||||||||||||||||
38 | Process (internal) Control | Choices are: Included / Excluded / NA = not applicable some free text added sometimes | Adveritas file | |||||||||||||||||||||||
39 | Positive Control | Choices are: Included / Excluded / NA = not applicable some free text added sometimes | Adveritas file | |||||||||||||||||||||||
40 | *Publications | URL for cited article | Adveritas file | |||||||||||||||||||||||
41 | *IFU | URL for the package insert | Adveritas file | |||||||||||||||||||||||
42 | *Letter of Authorization (EUA) | URL for the EUA letter | Adveritas file | |||||||||||||||||||||||
43 | Creation Date | date listed on FDA website as date created | Adveritas file | |||||||||||||||||||||||
44 | Modified Date | date listed on FDA website as date modified | Adveritas file | |||||||||||||||||||||||
45 | Needs Review | Flag for internal work | Adveritas file | |||||||||||||||||||||||
46 | Vendor Analyte Name | LIVD specification column | ||||||||||||||||||||||||
47 | Vendor Result Description - gets spilt into Scale, QL and QN representation | LIVD specification column | ||||||||||||||||||||||||
48 | Test Performed LOINC Code | LIVD specification column | ||||||||||||||||||||||||
49 | Test Performed LOINC Long Name | LIVD specification column | ||||||||||||||||||||||||
50 | Test Ordered LOINC Code | LIVD specification column | ||||||||||||||||||||||||
51 | Test Ordered LOINC Long Name | LIVD specification column | ||||||||||||||||||||||||
52 | Vendor Comment | LIVD specification column | ||||||||||||||||||||||||
53 | Vendor Analyte Code | LIVD specification column | ||||||||||||||||||||||||
54 | Vendor Reference ID | LIVD specification column | ||||||||||||||||||||||||
55 | Testkit Name ID | LIVD specification column | ||||||||||||||||||||||||
56 | Testkit Name ID Type | LIVD specification column | ||||||||||||||||||||||||
57 | LOINC Component | LIVD specification column | ||||||||||||||||||||||||
58 | LOINC Property | LIVD specification column | ||||||||||||||||||||||||
59 | LOINC Time | LIVD specification column | ||||||||||||||||||||||||
60 | LOINC System | LIVD specification column | ||||||||||||||||||||||||
61 | LOINC Scale | LIVD specification column | ||||||||||||||||||||||||
62 | LOINC Method | LIVD specification column | ||||||||||||||||||||||||
63 | LOINC Version ID | LIVD specification column | ||||||||||||||||||||||||
64 | SORT / Row# | Column header from LIDR group K+ file | ||||||||||||||||||||||||
65 | Harmonization Indicator | Column header from LIDR group K+ file | ||||||||||||||||||||||||
66 | Clinical Context needed for mapping | Column header from LIDR group K+ file | ||||||||||||||||||||||||
67 | Source of entry | Column header from LIDR group K+ file | ||||||||||||||||||||||||
68 | Committee Reviewed | Column header from LIDR group K+ file | ||||||||||||||||||||||||
69 | Vendor Reviewed | Column header from LIDR group K+ file | ||||||||||||||||||||||||
70 | Standard name? | Column header from LIDR group K+ file | ||||||||||||||||||||||||
71 | Result scale (QL Nar, QL Nom, QL ord, QN, semiQN) | Column header from LIDR group K+ file | ||||||||||||||||||||||||
72 | Result Value Set (QL results) | Column header from LIDR group K+ file | ||||||||||||||||||||||||
73 | Units of measure | Column header from LIDR group K+ file | ||||||||||||||||||||||||
74 | Reference Range | Column header from LIDR group K+ file | ||||||||||||||||||||||||
75 | Mapping Date | Column header from LIDR group K+ file | ||||||||||||||||||||||||
76 | Generic Notes for any other information we get | Column header from LIDR group K+ file | ||||||||||||||||||||||||
77 | All EUA Attributes | Combines all the listed FDA attributes in the FDA table - this list grew over time | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
78 | Show All Serial Rows | Supports filtering on rows showing tests authorized for only for serial testing | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
79 | Show All Screening Rows | Supports filtering on rows showing tests authorized for screening use | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
80 | Show All Pooling Rows | Supports filtering on rows showing tests authorized for use on pooled specimen | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
81 | Show All Home Testing Rows | Supports filtering on rows showing tests authorized for at home testing | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
82 | Serial Testing | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
83 | Screening | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
84 | Serial Screening | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
85 | Pooling | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
86 | Pooled Serial Screening - Media | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
87 | Pooled Serial Screening - Swab | Expanded LIVD file in use by CDC | ||||||||||||||||||||||||
88 | Visual or Instrument Read | Indicates whether the result is produced by the instrument or create by visual read (applies to At-Home tests) | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
89 | Qualitative or Quantitative Result | indicator for scale of the test | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
90 | Single or Multiple Targets | Indicates if a PCR test targets a single gen or more than one gene | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
91 | Multi-analyte | Test targets more than one organism (also known as mulit-plex | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
92 | Saliva | Allows filtering on all tests allowed on saliva | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
93 | Fingerstick | Allows blood collection via fingerstick method (capillary blood) | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
94 | Direct to Consumer FDA designation (DTC) | Indicates that consumers can buy this test over the counter (testing is at a lab) | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
95 | Home Collection | Documents home collection procedure (not necessarily an at-home test) | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
96 | Collection Kit | Documents collection procedure | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
97 | Non-prescription Testing | test does not require an order by a provider | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
98 | Prescription Home Testing | Test requires an order by a provider, but then can be executed by consumer | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
99 | Over the Counter (OTC) Home Testing | Test can be bought by consumer and used by consumer (not performed by lab professional) | Expanded LIVD file in use by CDC | |||||||||||||||||||||||
100 | Telehealth Proctor Supervised | At home testing under supervision | Expanded LIVD file in use by CDC |